Searched for
PATENT CLIFF
Biopharma Shakti: India targets China dependence, patent cliffIndia is launching a major initiative to boost its biopharmaceutical manufacturing. This plan aims to reduce reliance on China for crucial ...05 Feb, 2026, 07.47 AM IST- Budget 2026 gives biologics & biosimilars a major policy boostIndia is set to become a global biopharmaceutical manufacturing hub. Finance Minister Nirmala Sitharaman announced a dedicated ₹10,000 cror...01 Feb, 2026, 11.47 PM IST
- US tariff a bitter pill for Indian pharmaDonald Trump's tariffs will impact Indian medicine exports. This policy targets branded and patented drugs. Indian generic drug makers face...28 Sep, 2025, 11.11 PM IST
- Novartis CEO 'very confident' on sales target, doesn't fear patent cliffNovartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday.02 Nov, 2024, 03.24 PM IST
- 3 reasons why Indian pharma is getting ready for unstoppable growthFor Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership i...07 Sep, 2024, 10.53 AM IST
- Patent cliff can turn Indian pharma stocks into investor’s goldminePharma stocks have surged due to a 'Patent Cliff,' where numerous drug patents expire, allowing generic manufacturers, especially in India,...31 Aug, 2024, 10.38 AM IST
- Generic drug industry to touch $27.9 bn by 2020: StudyGenerics would account for 85 per cent share in the domestic pharma market by 2020, fuelled by cheap labour, patent cliff of blockbuster dr...09 Sep, 2015, 06.29 PM IST
- Lack of initiative in drug discovery ails India: Dhaval Kumar Patel, NovartisOne of the biggest concerns about India, according to Patel, is that the country is still way behind others in global advancements made in ...02 Sep, 2014, 02.55 AM IST
- US exports may drive top Indian pharma cos to grow 20% in 2013"We believe that top players of the sector will continue to grow strongly in 2013, primarily led by exports.03 Feb, 2013, 12.07 PM IST
- Biologics worth $50 bn to lose patent protection in USA:Report"It is estimated that between 2009 and 2019, 21 biologics with a market value of over $ 50 billion will lose patent protection in the US al...31 Jan, 2013, 05.06 PM IST
- ‘Patent cliff’ forces pharmaceuticals companies to eye new marketsCompanies like Dr Reddy’s , Ranbaxy, Glenmark and Zydus Cadila have readied a strategy to counter the scenario , which is set to become cha...24 Dec, 2012, 11.13 AM IST
- Patent expiries: Dr Reddy's, Lupin to foray into specialty pharma, Aurobindo Pharma to focus on servicesIndia's top pharmaceutical companies are preparing for life after high revenues from expiring patents drops off at the end of this year.12 Sep, 2012, 07.53 AM IST
- Pharma cos may have to shift business strategy due to slow growth: ReportDrug makers might have to shift their business strategy as an overcrowded US market and peaking opportunities threaten to slow down growth.10 Jul, 2012, 05.28 AM IST
- Indian pharma companies like Ranbaxy, Dr Reddy’s & others eye $1bn generic opportunityIn the wake of patent expiries on three blockbuster drugs over the last six-seven months, an opportunity worth nearly $1.3 billion is up fo...13 Jun, 2012, 10.46 AM IST
- Pharmaceutical and healthcare sector to dominate M&As in 2012: Grant ThorntonIndia will see the largest number of M&As in pharmaceutical and healthcare sector this year despite regulations, according to Grant Thornto...21 Feb, 2012, 02.09 AM IST
- Companies to gain as Big Pharma goes genericFaced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.04 Oct, 2011, 08.05 AM IST
- Sony slaps patent violation complaint against LG ElectronicsJapanese major Sony Corp has filed a patent-infringement complaint against rival LG Electronics related to certain mobile phones and modems.30 Dec, 2010, 04.59 PM IST
Load More
